151
Discontinuation of Cholinesterase Inhibitors for the Treatment of Severe Alzheimer’s Disease
Condition(s):Alzheimer’s Disease; DementiaLast Updated:April 28, 2017Completed
Donepezil Hydrochloride 5 Mg: 168 Clinical Trials, Page 16 of 17
Hide Studies Not Open or Pending
152
Population Pharmacokinetic-pharmacodynamic (PK-PD) Modeling of Co-administered Gabapentin in Neuropathic Pain
Condition(s):Post-traumatic Neuropathic PainLast Updated:October 12, 2011Completed
153
Study Evaluating Lecozotan SR in Mild to Moderate Alzheimer’s Disease (AD)
Condition(s):Alzheimer DiseaseLast Updated:May 6, 2022Completed
154
E2022 Patch Formulation Single Dose Phase I Study
Condition(s):Japanese Healthy Male Adult VolunteersLast Updated:May 14, 2013Completed
155
Assessment of Cholinergic and Cognitive Function Using Pharmacologic ASL-Perfusion MRI
Condition(s):Cholinergic FunctionLast Updated:January 4, 2013Completed
156
Brain Correlates of Multimodal Rehabilitation in Chronic Post-stroke Aphasia
Condition(s):Aphasia; StrokeLast Updated:November 5, 2020Completed
157
A Study of RO4602522 in Participants With Moderate Severity Alzheimer Disease on Background Alzheimer Disease Therapy
Condition(s):Alzheimer’s DiseaseLast Updated:May 30, 2017Completed
158
Efficacy and Safety of Tianzhi Granule in Mild to Moderate Vascular Dementia
Condition(s):Vascular DementiaLast Updated:January 7, 2020Completed
159
Pharmacokinetics and Pharmacodynamics (PK/PD) of CEP-26401 in Healthy Subjects
Condition(s):Cognitive ImpairmentLast Updated:April 3, 2014Completed
160
A Healthy Volunteer Study to Evaluate Reversibility of Induced Impairment of Cognition
Condition(s):CognitionLast Updated:May 10, 2010Completed